
Fexofenadine + Pseudoephedrine
Form: ER Tablet
Strength: 12 Hr(Fexofenadine 60 mg + Pseudoephedrine 120 mg); 24 Hr(Fexofenadine 180 mg + Pseudoephedrine 240 mg)
Reference Brands: Allegra-D(US); Telfast-D(EU)
Category: Allergy Medication
Allegra-D / Telfast-D – Fexofenadine + Pseudoephedrine Tablets | Pharma B2B EU & US Allegra-D / Telfast-D combines Fexofenadine HCl (60 mg or 180 mg) with Pseudoephedrine (120 mg) to offer powerful allergy and nasal decongestion relief. Widely used for seasonal allergic rhinitis, it delivers 24-hour, non-drowsy symptom control. Available in extended-release tablets, approved by US FDA and compliant with EU GMP standards. Ideal for B2B pharma distribution, bulk export, and private labeling. Includes full documentation: COA, MSDS, and stability data.
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Related Products
Budesonide
Strength: 32 mcg, 64 mcg per spray
Form: Nasal Spray
Reference Brands: Rhinocort®(US). Budelin®(EU)
View DetailsBeclomethasone Inhaler
Strength: 100 mcg, 200 mcg/dose
Form: inahaler
Reference Brands: QVAR RediHaler®(US)
View DetailsBeclomethasone
Strength: 50 mcg/spray
Form: Nasal Spray
Reference Brands: Beconase AQ®(US & EU)
View DetailsMometasone
Strength: 50 mcg/spray
Form: Nasal Spray
Reference Brands: Nasonex®(US), Momekort®(EU)
View Details